TLDR
- ENPH dropped as much as 8.78%, trading around $36.40 on very low volume — just 1.32M vs. an average of 6.7M
- Pomerantz LLP filed a securities class action lawsuit, claiming Enphase misled the market on inventory management and expiring solar tax credits
- China’s new export tax policy sparked a sector-wide solar sell-off, raising expected input costs
- Jefferies cut its price target on ENPH, citing doubts over 2026 growth targets
- Analyst consensus sits at “Hold” with a $43.17 price target; Goldman Sachs is bullish at $51, Morgan Stanley bearish at $30
Enphase Energy had a rough session on April 2, 2026. The stock fell close to 9% intraday, weighed down by a combination of legal trouble, sector pressure, and a cautious Wall Street.
The drop came on unusually thin volume. Only around 1.32 million units changed hands, compared to the stock’s daily average of about 6.7 million. That’s an 80% drop in activity — suggesting many investors simply stepped aside rather than rushing to sell.
The biggest headline driving the move was a newly filed securities class action lawsuit from Pomerantz LLP. The firm alleges that Enphase misled investors about how it was handling inventory and about the impact of expiring solar tax credits. Legal risk of this kind tends to spook the market quickly, and it did here.
At the same time, the broader solar sector was under pressure. China announced a new export tax policy that’s expected to push up costs for key solar components. Since Enphase relies on a global supply chain, higher input costs are a real concern for margins going forward.
Jefferies Cuts Price Target
Jefferies added to the pressure by trimming its price target on ENPH. The bank cited growing doubts that Enphase can hit its 2026 growth goals — a meaningful signal given the already fragile sentiment around the stock.
The technical picture isn’t pretty either. ENPH is trading below its 50-day moving average of $43.13, and the stock’s technical sentiment signal is listed as a “Strong Sell.” Year-to-date, the stock is still down about 19.44%.
Analyst opinion is split. Goldman Sachs has a buy rating with a $51 price target, while Morgan Stanley stays underweight at $30. The consensus across 31 analysts is a “Hold” with a target of $43.17 — still well above where the stock is currently trading.
Recent Earnings Were a Mixed Bag
Enphase’s most recent quarterly results, reported in February, showed an EPS beat — $0.71 versus the $0.52 expected. But revenue of $343.3 million was down 10.3% year-over-year, a trend that hasn’t helped sentiment.
CEO Badrinarayanan Kothandaraman bought 5,000 units at around $51.98 back in early February — a sign of internal confidence, though the stock has since fallen well below that level. A director did sell 1,100 units around the same time.
Institutions hold 72.12% of the stock, and insiders own 3.1%. Market cap sits at approximately $5.02 billion as of this session.
Jefferies’ target cut and the Pomerantz lawsuit filing are the most recent material developments in the ENPH story.







